Iain Dukes - 01 Nov 2024 Form 4 Insider Report for Lomond Therapeutics Holdings, Inc. (NONE)

Role
CEO and Chairman, Director
Signature
/s/ Iain D. Dukes
Issuer symbol
NONE
Transactions as of
01 Nov 2024
Net transactions value
$0
Form type
4
Filing time
05 Nov 2024, 18:00:12 UTC
Previous filing
13 Jun 2024
Next filing
17 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NONE Stock Option (Right to Buy) Award $0 +2,096,667 $0.000000 2,096,667 01 Nov 2024 Common Stock 2,096,667 $1.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting monthly after November 1, 2024, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.